Unfortunately, by the time you are symptomatic with a virus, you are usually already high/peak viral load. So, when you give an antiviral to someone who is already ill, the damage from the virus is largely done. It’s there in big numbers and in the cells.
-
-
Before we have the answer whether this drug actually changes anyone’s destiny, it’s going to become the gold standard therapy. We will likely now never know if (the unlikely possibility) it changes mortality.
Show this thread -
Absolute genius. You have to salute them. On the day a negative trial of their drug is reported, based on a press release they took over the news cycle, and with some midstream edits to their endpoints their now “positive” trial wins them FDA approval and a halted trial.
Show this thread -
It’s an infusion, once symptomatic, you need an admission, a test, etc., really even symptoms are probably too late a goal for such a therapy to work. Prophylaxis (like Gilead’s Truvada/PreP would be better - but unworkable in its current form.
Show this thread -
Either way, a big win for Gilead, but I’m unimpressed with any if the evidence presented so far that this is a game changer.
Show this thread
End of conversation
New conversation -
-
-
Aren't there ongoing clinical trials that will give us more information as to its potential effectiveness?
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
You're really bumming me out w/this thread. I'm not a science person. Is there anything you've seen reported that you ARE hopeful about to treat/prevent Covid 19?
-
No. If anything we persistently are going in the wrong directions, have not ramped testing and tracing, and have schizo leadership that, if anything, appear hell bent on killing us by stopping lockdown too soon and pursuing only the answers they want to hear.
- Show replies
New conversation -
-
-
It changes the destiny and wealth of Gilead
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
That's overlooking the other trials that already have been studying the drug. We will be able to do a meta analysis to have better estimates. Also Gilead has made commendable commitments to make the drug affordable
-
The time to recovery endpoint is quite relevant when you're in a pandemic situation and your hospitals threaten to be overrun
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.